Skip to main content
Article thumbnail
Location of Repository

Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study

By Thomas P Ahern, Timothy L Lash, Henrik T Sørensen and Lars Pedersen
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2001). A: Risk factors for male breast cancer – a case-control study from Scandinavia. Acta Oncol
    2. (2003). Aperia A: Na, K-ATPase as a signal transducer.
    3. (1982). Cardiac glycosides and breast cancer, revisited.
    4. (1984). Digitalis and breast cancer. Lancet
    5. (2001). Digitoxin medication and cancer; case control and internal dose-response studies.
    6. (1998). Fauci AS: Harrison's Principles of Internal Medicine 14th edition.
    7. (1979). GA: Digoxin and hormone receptors. Lancet
    8. (2008). Hormone replacement therapy and the risk of breast cancer.
    9. (2003). HT: Risk of acute pancreatitis in users of azathioprine: a population-based case-control study.
    10. (1999). Is digitalis a therapy for breast carcinoma? Oncol Rep
    11. (2005). JA: Use of antibiotics and risk of breast cancer: a populationbased case-control study.
    12. (2008). JA: Use of bisphosphonates among women and risk of atrial fibrillation and flutter: population based case-control study. BMJ
    13. (2008). JA: Use of common medications and breast cancer risk. Cancer Epidemiol Biomarkers Prev
    14. (2008). KI: Cardiac glycosides as novel cancer therapeutic agents. Mol Interv
    15. (2000). Lindmarker P: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism.
    16. (1976). Loriaux DL: Mechanism of interaction of digitalis with estradiol binding sites in rat uteri. Endocrinology
    17. (2004). Neugut AI: Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA
    18. Organization: WHO Collaborating Center for Drug Statistics Methodology.
    19. (2008). PA: Impact of obesity on cardiovascular disease. Endocrinol Metab Clin North Am
    20. (2005). Russo IH: The protective role of pregnancy in breast cancer. Breast Cancer Res
    21. (2005). Screening for estrogenicity and antiestrogenicity: a critical evaluation of an MVLN cell-based transactivation assay. Toxicol Lett
    22. (2008). Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differ-Breast
    23. (2006). Sodium/potassium ATPase (Na+, K+-ATPase) and ouabain/related cardiac glycosides: A new paradigm for development of anti- breast cancer drugs? Breast Cancer Res Treat
    24. (2008). Sørensen HT: Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram.
    25. (2007). The digitalis-like steroid hormones: new mechanisms of action and biological significance. Life Sci
    26. TL: Case-control studies.
    27. TL: Validity in epidemiologic studies.
    28. (2008). Weiderpass E: Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol
    29. (1979). Westman-Naeser S: Cardiac glycosides and breast cancer. Lancet
    30. (1980). Westman-Naeser S: Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol
    31. (2000). When an entire country is a cohort. Science

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.